转化医学在中国:五年回顾与展望  

Review and prospect of translational medicine in China

作　　者：时占祥 詹启敏 顾申[3] 何昆仑[4] 李宁[5] 孙毅[6] 辛洪波[7] 冯毅 安建雄[9] 刘合焜[10] 李海燕[11] 陈俭[6] 罗迪贤[12] 梁虹 王正国[13] 付小兵[4] 

机构地区：[1]全球医生组织(北京代表处),北京100036 [2]中国医学科学院肿瘤研究所,北京100730 [3]第二军医大学转化医学研究院,上海200433 [4]中国人民解放军总医院转化医学中心,北京100037 [5]首都医科大学附属北京佑安医院,北京100069 [6]浙江大学转化医学研究院,杭州310029 [7]南昌大学转化医学研究院,南昌330031 [8]科文顿.柏灵律师事务所,北京100022 [9]中国科学院北京转化医学研究院,北京100012 [10]福建医科大学转化医学研究院,福州350108 [11]首都医科大学科技处,北京100069 [12]湖南省郴州市第一人民医院南华大学转化医学研究所,郴州423000 [13]第三军医大学附属大坪医院,重庆400042

出　　处：《科学通报》2015年第22期2151-2156,共6页Chinese Science Bulletin

摘　　要：近5年来,转化医学在中国完成了从理念到实践落地的转变,初步统计已建立了130多家各具特色的转化医学研究机构,重点关注重大疾病的临床与转化研究与合作.但同时也应当看到转化医学学科建设仍面临严峻的现实:一方面缺乏顶层的统筹规划和专项经费投入,以解决转化研究项目难以落实、研究资源与技术碎片化的问题;另一方面缺乏与国家科技战略发展相配合的激励机制和专业人才培养等.本文针对上述问题对"十三五"阶段我国转化医学领域的发展框架提出了初步建议.During the past five years, translational medicine has completed the transformation from the concept to practice landed in China. A preliminary survey data has shown that more than 130 translational medicine research institutions or centers have been established in China, focusing on clinical and translational research in those major diseases areas. Meanwhile, the scientific disciplines of translational medicine are still facing the grim reality. On the one hand, the top level of design, the master plan and the dedicated research funds need to been strengthen, in order to achieve the transformation of clinical and translational projects and to resolve the problems of fragmentation on research resources and technology applications. On the other hand, the incentive mechanism and professional talent training in coordination with the national science and technology development strategy are still little paid attention. This article alms to suggest the translational medicine development framework of the Chinese＇s thirteen-five year national plan.

关 键 词：转化医学 顶层设计 “十三五”规划 转化医学研究中心/院 临床研究 

分 类 号：R-05[医药卫生]